Our Team

Our Team

Many soft tissue sarcomas have grown to an advanced stage by the time they are diagnosed. For this reason, receiving care at an academic medical center is important. Here, treatments are based on the findings of the latest medical research and clinical trials of investigational therapies are available.

NewYork-Presbyterian is home to a top multidisciplinary Sarcoma Center on the East Coast. Our collaborative team includes surgeons, medical oncologists, radiation oncologists, pathologists, oncology nurses, social workers, psychosocial support specialists, and others with exceptional experience in caring for people with sarcoma and their families.

Our Approach to Care

Our Approach to Care

At NewYork-Presbyterian, a team of sarcoma experts from different surgical and medical disciplines meets regularly to discuss your care and tailor a treatment plan to your needs. For many people with soft tissue sarcomas, access to innovative therapies in clinical trials offers the most hope, and we participate in these vital studies. Patients come to us from across the country and around the world for this high level of care.

Supportive Care

Our nutritionists, social workers, rehabilitation therapists, palliative care experts, and others will help you and your loved ones address the effects of cancer and its treatment — physical, emotional, and spiritual. We understand the burden that cancer can place on your life and the lives of your loved ones, and we do whatever we can to lessen that burden.

Care for coexisting conditions

NewYork-Presbyterian is known throughout the world as a leading provider of health care. As a major medical center, we can address your healthcare needs, such as co-existing conditions like heart disease and diabetes, and connect you with the specialists you need.

Clinical trials

We participate in clinical trials to evaluate new approaches to caring for people with soft tissue sarcomas, including leading new studies and participating in multicenter national and international studies. Many of these studies are evaluating targeted therapies for soft tissue sarcoma and immunotherapies — treatments that boost the immune system's power to find and destroy sarcoma cells. You may have the opportunity to participate in a clinical trial of a promising new therapy.

Learn more about our clinical trials